| Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles J Morry, W Ngamcherdtrakul, W Yantasee Redox biology 11, 240-253, 2017 | 344 | 2017 |
| Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer W Ngamcherdtrakul, J Morry, S Gu, DJ Castro, SM Goodyear, ... Advanced functional materials 25 (18), 2646-2659, 2015 | 193 | 2015 |
| Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment M Reda, W Ngamcherdtrakul, MA Nelson, N Siriwon, R Wang, HY Zaidan, ... Nature communications 13 (1), 4261, 2022 | 78 | 2022 |
| Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis J Morry, W Ngamcherdtrakul, S Gu, SM Goodyear, DJ Castro, MM Reda, ... Biomaterials 66, 41-52, 2015 | 71 | 2015 |
| Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer MA Nelson, W Ngamcherdtrakul, SW Luoh, W Yantasee Cancer and Metastasis Reviews 40 (2), 519-536, 2021 | 70 | 2021 |
| Novel oral detoxification of mercury, cadmium, and lead with thiol-modified nanoporous silica T Sangvanich, J Morry, C Fox, W Ngamcherdtrakul, S Goodyear, D Castro, ... ACS applied materials & interfaces 6 (8), 5483-5493, 2014 | 61 | 2014 |
| Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery W Ngamcherdtrakul, T Sangvanich, M Reda, S Gu, D Bejan, W Yantasee International journal of nanomedicine, 4015-4027, 2018 | 59 | 2018 |
| Targeted treatment of metastatic breast cancer by PLK1 siRNA delivered by an antioxidant nanoparticle platform J Morry, W Ngamcherdtrakul, S Gu, M Reda, DJ Castro, T Sangvanich, ... Molecular cancer therapeutics 16 (4), 763-772, 2017 | 59 | 2017 |
| PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer M Reda, W Ngamcherdtrakul, S Gu, DS Bejan, N Siriwon, JW Gray, ... Cancer letters 467, 9-18, 2019 | 56 | 2019 |
| siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion W Ngamcherdtrakul, W Yantasee Translational Research 214, 105-120, 2019 | 55 | 2019 |
| In situ tumor vaccination with nanoparticle co‐delivering CpG and STAT3 siRNA to effectively induce whole‐body antitumor immune response W Ngamcherdtrakul, M Reda, MA Nelson, R Wang, HY Zaidan, DS Bejan, ... Advanced Materials 33 (31), 2100628, 2021 | 44 | 2021 |
| Therapeutic siRNA for drug-resistant HER2-positive breast cancer S Gu, Z Hu, W Ngamcherdtrakul, DJ Castro, J Morry, MM Reda, JW Gray, ... Oncotarget 7 (12), 14727, 2016 | 42 | 2016 |
| Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery R Salve, P Kumar, W Ngamcherdtrakul, V Gajbhiye, W Yantasee Materials Science and Engineering: C 124, 112084, 2021 | 32 | 2021 |
| Current development of targeted oligonucleotide-based cancer therapies: perspective on HER2-positive breast cancer treatment W Ngamcherdtrakul, DJ Castro, S Gu, J Morry, M Reda, JW Gray, ... Cancer treatment reviews 45, 19-29, 2016 | 30 | 2016 |
| Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain … W Ngamcherdtrakul, DS Bejan, W Cruz‐Muņoz, M Reda, HY Zaidan, ... Small 18 (11), 2107550, 2022 | 28 | 2022 |
| Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment S Gu, W Ngamcherdtrakul, M Reda, Z Hu, JW Gray, W Yantasee PloS one 13 (6), e0198141, 2018 | 24 | 2018 |
| Selective capture of radionuclides (U, Pu, Th, Am and Co) using functional nanoporous sorbents W Yantasee, GE Fryxell, K Pattamakomsan, T Sangvanich, RJ Wiacek, ... Journal of hazardous materials 366, 677-683, 2019 | 21 | 2019 |
| Cross-linked polymer modified nanoparticles W Yantasee, W Ngamcherdtrakul, J Morry, D Castro, J Gray US Patent 11,207,428, 2021 | 12 | 2021 |
| Lanthanide-loaded nanoparticles as potential fluorescent and mass probes for high-content protein analysis W Ngamcherdtrakul, T Sangvanich, S Goodyear, M Reda, S Gu, ... Bioengineering 6 (1), 23, 2019 | 9 | 2019 |
| Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model W Ngamcherdtrakul, J Morry, T Sangvanich, M Reda, DS Bejan, ... Scientific Reports 9 (1), 709, 2019 | 7 | 2019 |
